(Q46474251)

22 December 2017

title

Combined use of ivermectin and triclabendazole in sheep: in vitro and in vivo characterisation of their pharmacological interaction (English)

1 reference

22 December 2017

0 references

1 reference

Adrian Lifschitz

1

1 reference

22 December 2017

Guillermo Virkel

2

1 reference

22 December 2017

Mariana Ballent

3

1 reference

22 December 2017

Juan Sallovitz

4

1 reference

22 December 2017

Carlos Lanusse

5

1 reference

22 December 2017

publication date

18 July 2008

1 reference

22 December 2017

published in

The Veterinary Journal

1 reference

22 December 2017

volume

182

1 reference

22 December 2017

issue

2

1 reference

22 December 2017

page(s)

261-268

1 reference

22 December 2017

Evaluation of the interaction between ivermectin and albendazole following their combined use in lambs

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.06.001

Modulation of the P-glycoprotein-mediated intestinal secretion of ivermectin: in vitro and in vivo assessments.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.06.001

Involvement of P-glycoprotein on ivermectin kinetic behaviour in sheep: itraconazole-mediated changes on gastrointestinal disposition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.06.001

Worm control and anthelmintic resistance: adventures with a model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.06.001

Transporter-Enzyme Interactions: Implications for Predicting Drug-Drug Interactions from In Vitro Data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.06.001

Treatment of immature and mature Fasciola hepatica infections in sheep with triclabendazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.06.001

Ivermectin: a review of efficacy and safety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.06.001

Pharmacokinetics of a novel closantel/ivermectin injection in cattle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.06.001

Liquid chromatographic determination of ivermectin in animal plasma with trifluoroacetic anhydride and N-methylimidazole as the derivatization reagent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.06.001

The abamectin derivative ivermectin is a potent P-glycoprotein inhibitor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.06.001

Relevance of p-glycoprotein for the enteral absorption of cyclosporin A: in vitro-in vivo correlation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.06.001

What is the true risk of a pharmacokinetic drug-drug interaction?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.06.001

The kinetics of triclabendazole disposition in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.06.001

Ivermectin binds avidly to plasma proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.06.001

Intestinal secretion is a major route for parent ivermectin elimination in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.06.001

Interaction of macrocyclic lactones with P-glycoprotein: structure-affinity relationship

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.06.001

Comparative distribution of ivermectin and doramectin to parasite location tissues in cattle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.06.001

Loperamide modifies the tissue disposition kinetics of ivermectin in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.06.001

Drug-drug interaction mediated by inhibition and induction of P-glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.06.001

Transporter-mediated drug interactions: clinical implications and in vitro assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.06.001

Concise review: Clinical relevance of drug drug and herb drug interactions mediated by the ABC transporter ABCB1 (MDR1, P-glycoprotein).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.06.001

Avermectins and milbemycins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.06.001

Resistance-induced changes in triclabendazole transport in Fasciola hepatica: ivermectin reversal effect.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.06.001

Noncompartmental determination of the steady-state volume of distribution for any mode of administration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.06.001

Assessment of the main metabolism pathways for the flukicidal compound triclabendazole in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.06.001

10.1016/J.TVJL.2008.06.001

7 January 2021

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017